Investing in Venus Remedies not safe at this point: Ashuu Kakkarr, Market Strategist
Ashuu Kakkarr, Technical Analyst, Market Strategist, in a chat with ET Now talks about Venus Remedies.
By 
|
| Ashuu Kakkarr, Technical Analyst, Market Strategist, in a chat with ET Now talks about Venus Remedies.
Are you positive on Venus Remedies after the 15% bump up that we have already seen?
To get into for an investment into this stock at this point of time doesn’t look safe on the risk reward ratio. But nevertheless, I think the pharma stocks have been safe havens for the stock markets. My favourites would be Ranbaxy and Cipla and Dr Reddy would be the first pick
So probably I think Dr. Reddy still has got some more steam left. Venus Remedies - I haven’t seen the stock in the last couple of weeks So I think it would not be wise to comment on that.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
